All In MedTech

Device Trial Radar · NCT03156010

Oculomotor Assessment of Traumatic Brain Injury (TBI)

Last checked: Nov 19, 2026Latest source record: Aug 23, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 201 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

201

Actual

Start

Sep 18, 2017

Primary completion

Apr 19, 2023

Study completion Apr 19, 2023

Sponsor

Sponsor type
Federal agency
Collaborators
Neurolign; Sync-Think, Inc.; Oculogica, Inc.; TBICoE; United States Department of Defense
First posted
May 16, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the proposed study is to compare the sensitivity and specificity of three oculomotor test devices in normal subjects versus subjects with history of TBI. The study is designed as a prospective research project in which a group of 120 normal controls without a history of TBI will be compared to another group of 120 participants (total of 240) who have a confirmed history of TBI. Each participant will complete the TBI assessment protocol for each of three separate devices (Neuro Kinetics, SyncThink, and Oculogica). The order of the devices will be counter-balanced across participants. Participants will also be screened for vestibular migraine and visual vertigo, which are two conditions that influence oculo-vestibular perception in normal and TBI patients and might influence the results from the three oculomotor devices. Data from each device will be utilized to perform AUC analyses to determine the respective sensitivity and specificity for each.

Conditions

  • Traumatic Brain Injury

Interventions

  • Neuro Kinetics IPASDevice

    Testing with PAS device

  • Oculogica EyeBoxDevice

    Testing with Oculogica EyeBox device

  • SyncThink EyeSync DeviceDevice

    Testing with SyncThink EyeSync device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area Under the Curve (AUC)Time frame: Single test session (1.5 hours) - all testing performed at time of study enrollment, will be reported at conclusion of data collection as all data is required to generate AUCs.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National Intrepid Center of Excellence

    Bethesda, Maryland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.